Botanic Healthcare launches Rs. 25 crore liposomal manufacturing facility in Hyderabad
New unit boosts innovation in liposomal delivery technologies with 8,500 MT capacity and export-ready production
New unit boosts innovation in liposomal delivery technologies with 8,500 MT capacity and export-ready production
Nuvaxovid is the only protein-based, non-mRNA COVID-19 vaccine available in the U.S. for the 2025-2026 vaccination season
This year, the OCTF focused on preparing a white paper on oral cancer elimination in India and updating its annual consensus guidelines
The approval in China is supported by a robust local clinical development program confirming the drug’s safety, tolerability, and efficacy profile
This is the second and final phase of the overall capacity addition of ?195 kL which was under construction at Unit IV Bidar facility
Genomics is transforming the future of modern medicine and treatment modalities across specialties
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L
Subscribe To Our Newsletter & Stay Updated